• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌治疗后遗症的呼吸物理治疗干预策略:系统评价。

Respiratory Physiotherapy Intervention Strategies in the Sequelae of Breast Cancer Treatment: A Systematic Review.

机构信息

Department of Nursing and Physiotherapy, University of Cadiz, 11009 Cadiz, Spain.

Rehabilitation Clinical Management Unit, Interlevels-Intercenters Hospital Puerta del Mar, Hospital Puerto Real, Cadiz Bay-La Janda Health District, 11006 Cadiz, Spain.

出版信息

Int J Environ Res Public Health. 2022 Mar 23;19(7):3800. doi: 10.3390/ijerph19073800.

DOI:10.3390/ijerph19073800
PMID:35409486
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8997605/
Abstract

Breast cancer treatments can trigger respiratory sequelae. Respiratory physiotherapy helps to eliminate or mitigate the sequelae by optimizing respiratory function. This systematic review aims to synthesize the scientific evidence and assess its quality regarding the use of respiratory physiotherapy in the sequelae of breast cancer. The Cochrane Library, Physiotherapy Evidence Database, PubMed, Web of Science, Scientific Electronic Library Online, Cumulative Index of Nursing and Allied Literature Complete, and Scopus were searched. Study quality was determined using the PEDro scale, STROBE Statement, and Single-Case Experimental Design Scale. Ten studies, six clinical trials, one case study, and three observational studies were selected. The mean methodological quality of the clinical trials was 5.6, that of the case study was 7, and that of the observational studies was 56%. Respiratory physiotherapy has been observed to improve respiratory capacity, lung function, respiratory muscle strength, effort tolerance, dyspnea, fatigue, thoracic mobility, upper limb volume, sleep quality and quality of life, as well as sensitivity to adverse physiological reactions, nausea, vomiting, and anxiety. However, it is not effective for vasomotor symptoms. More clinical trials are needed. These studies should homogenize the techniques used, as well as improve their methodological quality.

摘要

乳腺癌治疗可能引发呼吸系统后遗症。呼吸理疗通过优化呼吸功能有助于消除或减轻这些后遗症。本系统综述旨在综合科学证据并评估其质量,以了解呼吸理疗在乳腺癌后遗症中的应用。检索了 Cochrane 图书馆、物理治疗证据数据库、PubMed、Web of Science、科学电子图书馆在线、护理学和相关文献累积索引完整版、以及 Scopus。使用 PEDro 量表、STROBE 声明和单病例实验设计量表来确定研究质量。选择了 10 项研究,其中 6 项为临床试验,1 项为病例研究,3 项为观察性研究。临床试验的平均方法学质量为 5.6,病例研究为 7,观察性研究为 56%。呼吸理疗可改善呼吸能力、肺功能、呼吸肌力量、耐受能力、呼吸困难、疲劳、胸壁活动度、上肢容量、睡眠质量和生活质量,以及对不良反应的敏感性、恶心、呕吐和焦虑。然而,它对血管舒缩症状无效。需要更多的临床试验。这些研究应使所使用的技术同质化,并提高其方法学质量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8154/8997605/e975cd96cdb7/ijerph-19-03800-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8154/8997605/593af41bb077/ijerph-19-03800-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8154/8997605/fca29c18555e/ijerph-19-03800-g0A2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8154/8997605/154baf618d02/ijerph-19-03800-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8154/8997605/080057231320/ijerph-19-03800-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8154/8997605/e975cd96cdb7/ijerph-19-03800-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8154/8997605/593af41bb077/ijerph-19-03800-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8154/8997605/fca29c18555e/ijerph-19-03800-g0A2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8154/8997605/154baf618d02/ijerph-19-03800-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8154/8997605/080057231320/ijerph-19-03800-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8154/8997605/e975cd96cdb7/ijerph-19-03800-g003.jpg

相似文献

1
Respiratory Physiotherapy Intervention Strategies in the Sequelae of Breast Cancer Treatment: A Systematic Review.乳腺癌治疗后遗症的呼吸物理治疗干预策略:系统评价。
Int J Environ Res Public Health. 2022 Mar 23;19(7):3800. doi: 10.3390/ijerph19073800.
2
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
3
Physiotherapy interventions for shoulder pain.针对肩部疼痛的物理治疗干预措施。
Cochrane Database Syst Rev. 2003;2003(2):CD004258. doi: 10.1002/14651858.CD004258.
4
Interventions for promoting habitual exercise in people living with and beyond cancer.促进癌症患者及康复者进行习惯性锻炼的干预措施。
Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3.
5
Interventions for palliative symptom control in COVID-19 patients.干预措施以控制 COVID-19 患者的姑息症状。
Cochrane Database Syst Rev. 2021 Aug 23;8(8):CD015061. doi: 10.1002/14651858.CD015061.
6
Autogenic drainage for airway clearance in cystic fibrosis.自主引流治疗囊性纤维化患者的气道清除。
Cochrane Database Syst Rev. 2021 Dec 15;12(12):CD009595. doi: 10.1002/14651858.CD009595.pub3.
7
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.拓扑替康、聚乙二醇化脂质体盐酸多柔比星和紫杉醇用于晚期卵巢癌二线或后续治疗:一项系统评价和经济学评估
Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. doi: 10.3310/hta10090.
8
Physical activity for women with breast cancer after adjuvant therapy.辅助治疗后乳腺癌女性的体育活动
Cochrane Database Syst Rev. 2018 Jan 29;1(1):CD011292. doi: 10.1002/14651858.CD011292.pub2.
9
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.

本文引用的文献

1
Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement.更新系统评价报告指南:PRISMA 2020 声明的制定。
J Clin Epidemiol. 2021 Jun;134:103-112. doi: 10.1016/j.jclinepi.2021.02.003. Epub 2021 Feb 9.
2
The effect of breathing exercise on nausea, vomiting and functional status in breast cancer patients undergoing chemotherapy.呼吸锻炼对接受化疗的乳腺癌患者恶心、呕吐和功能状态的影响。
Complement Ther Clin Pract. 2020 Aug;40:101213. doi: 10.1016/j.ctcp.2020.101213. Epub 2020 Jun 14.
3
Aerobic Exercise-Induced Changes in Cardiorespiratory Fitness in Breast Cancer Patients Receiving Chemotherapy: A Systematic Review and Meta-Analysis.
有氧运动对接受化疗的乳腺癌患者心肺适能的影响:一项系统评价与荟萃分析
Cancers (Basel). 2020 Aug 11;12(8):2240. doi: 10.3390/cancers12082240.
4
Exploring the Therapeutic Benefits of Pranayama (Yogic Breathing): A Systematic Review.探索调息法(瑜伽呼吸法)的治疗益处:一项系统综述。
Int J Yoga. 2020 May-Aug;13(2):99-110. doi: 10.4103/ijoy.IJOY_37_19. Epub 2020 May 1.
5
Long-term Cardiopulmonary Consequences of Treatment-Induced Cardiotoxicity in Survivors of ERBB2-Positive Breast Cancer.ERBB2 阳性乳腺癌幸存者治疗诱导性心脏毒性的长期心肺后果。
JAMA Cardiol. 2020 Mar 1;5(3):309-317. doi: 10.1001/jamacardio.2019.5586.
6
Is Xbox 360 Kinect-based virtual reality training as effective as standard physiotherapy in patients undergoing breast cancer surgery?基于 Xbox 360 Kinect 的虚拟现实训练与标准物理疗法在接受乳腺癌手术的患者中同样有效吗?
Support Care Cancer. 2020 Sep;28(9):4295-4303. doi: 10.1007/s00520-019-05287-x. Epub 2020 Jan 6.
7
The Influence of Soft Tissue Therapy on Respiratory Efficiency and Chest Mobility of Women Suffering from Breast Cancer.软组织治疗对乳腺癌女性呼吸效率和胸廓活动度的影响。
Int J Environ Res Public Health. 2019 Dec 13;16(24):5092. doi: 10.3390/ijerph16245092.
8
Diagnosis and Treatment of Breast Cancer in Men.男性乳腺癌的诊断与治疗
Radiol Technol. 2019 Sep;91(1):51M-61M.
9
Clinical Outcomes After Physical Therapy Treatment for Secondary Lymphedema After Breast Cancer.乳腺癌继发淋巴水肿物理治疗后的临床结果
Cureus. 2019 May 30;11(5):e4779. doi: 10.7759/cureus.4779.
10
Evaluation of the effectiveness of physiotherapy in patients after oncological breast cancer treatment based on spirometric indicators.基于肺量计指标评估乳腺癌肿瘤治疗后患者物理治疗的效果。
Contemp Oncol (Pozn). 2019;23(1):47-51. doi: 10.5114/wo.2019.82929. Epub 2019 Feb 18.